Market Research

Mesenchymal Stem Cells Market Size, Share & Trends Analysis Report By Products and Services (, Services), By Workflow (Cell Sourcing and Isolation, Culture and Cryopreservation, Differentiation, Characterization), By Type (Autologous, Allogeneic), By Sour

Best Price Guarantee Publisher Published Date SKU
from $3,500 Straits Research November, 2024 STRA19656433
Best Price Guarantee
Price from $3,500
Publisher Straits Research
Published Date November, 2024
SKU STRA19656433

Mesenchymal Stem Cells Market Analysis and Insights

The Mesenchymal Stem Cells Market size is anticipated to reach USD 3.0 billion in 2023 and it is projected to reach USD 9.4 billion by 2032, growing at a CAGR of 13.3% during the forecast period.

The Global Mesenchymal Stem Cells Market Analysis report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis.

The Global Mesenchymal Stem Cells Market growth, Size report provides a comprehensive analysis of the Biotechnology industry, analyzes and identifies changes in market conditions set to impact future business decisions by analyzing.

Research Methodology

Our research methodology constitutes a mix of secondary & primary research which ideally starts from exhaustive data mining, conducting primary interviews (suppliers/distributors/end-users), and formulating insights, estimates, growth rates accordingly. Final primary validation is a mandate to confirm our research findings with Key Opinion Leaders (KoLs), Industry Experts, Mesenchymal Stem Cells Market includes major supplies & Independent Consultants among others.

Global Market Scope and Mesenchymal Stem Cells Market

The scope of the report is to provide a 360-degree view of the market outlook by assessing the entire value chain and analyzing the key Mesenchymal Stem Cells Market trends from 2024 to 2032 underlying in specific geographies. Qualitative and quantitative aspects are interlinked to provide rationales on market numbers, CAGR, and forecasts.

Mesenchymal Stem Cells Market Country Level Analysis

The Global Mesenchymal Stem Cells Market Industry Analysis Research Report provides a basic overview of industry dominating market share expected 2024 to 2032. A detailed section on Mesenchymal Stem Cells Market share and status of critical industries is included in the report, covering. Market Segment by Regions (North America, Europe, Asia Pacific, South America and The Middle East and Africa), coverage with region wise data from 2024 to 2032.

Top Players in Mesenchymal Stem Cells Market

Some of the other major highlights of the demand for Mesenchymal Stem Cells Market include analysis, purchasing volume, prices, pricing analysis, and regulatory framework. Coverage on manufacturing structure, distribution channels, and Porter’s Five Forces analysis are also incorporated in the scope to provide analysis on the demand and supply side. This is anticipated to create opportunities for the growth of the Mesenchymal Stem Cells Market during the forecast period.

  • Thermo Fisher Scientific, Inc.
  • Cell Applications, Inc.
  • Axol Biosciences Ltd.
  • Cytori Therapeutics Inc
  • STEMCELL Technologies
  • Cyagen Biosciences.
  • Celprogen Inc
  • BrainStorm Cell Limited.
  • Stemedica Cell Technologies Inc
  • Merck KGaA (MilliporeSigma)
  • Lonza
  • PromoCell GmbH

Market Segmentation

The Global Mesenchymal Stem Cells Market Share, Demand provides the most up-to-date Biotechnology industry data on the actual market situation, size, trends and future outlook. The research includes historic data from 2021 to 2023 and forecasts until 2032.
  • By Products and Services
    • Products
      • Cells and Cell Lines
      • Kits, Media, and Reagents
    • Services
  • By Workflow
    • Cell Sourcing and Isolation
    • Culture and Cryopreservation
    • Differentiation
    • Characterization
  • By Type
    • Autologous
    • Allogeneic
  • By Source of Isolation
    • Bone Marrow
    • Cord Blood
    • Peripheral Blood
    • Fallopian Tube
    • Fetal Liver
    • Lung
    • Adipose Tissues
  • By Indication
    • Bone And Cartilage Repair
    • Cardiovascular Disease
    • Inflammatory And Immunological Diseases
    • Liver Diseases
    • Cancer
    • GvHD
  • By Application
    • Disease Modelling
    • Drug Development and Discovery
    • Stem Cell Banking
    • Tissue Engineering
    • Toxicology Studies

Regions Coverd
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Nordic
    • Benelux
    • Rest of Europe
  • APAC
    • China
    • Korea
    • Japan
    • India
    • Australia
    • Singapore
    • Taiwan
    • South East Asia
    • Rest of Asia-Pacific
  • Middle East and Africa
    • UAE
    • Turkey
    • Saudi Arabia
    • South Africa
    • Egypt
    • Nigeria
    • Rest of MEA
  • LATAM
    • Brazil
    • Mexico
    • Argentina
    • Chile
    • Colombia
    • Rest of LATAM

Reasons for Doing the Study:

This report is an update of an earlier (2023) Research study. Since the previous edition of this report was published, the Public Safety and Security market has continued to evolve. In particular, the overall market growth rates forecast in the previous edition now appear to have been too high, extending the time-line for the market’s development. In order to give its readers, the most up-to-date and accurate assessment of future market opportunities.


1 Executive Summary
2 Research Scope & Segmentation
2.1 Research Objectives
2.2 Limitations & Assumptions
2.3 Market Scope & Segmentation
2.4 Currency & Pricing Considered
3 Market Opportunity Assessment
3.1 Emerging Regions / Countries
3.2 Emerging Companies
3.3 Emerging Applications / End Use
4 Market Trends
4.1 Drivers
4.2 Market Warning Factors
4.3 Latest Macro Economic Indicators
4.4 Geopolitical Impact
4.5 Technology Factors
5 Market Assessment
5.1 Porters Five Forces Analysis
5.2 Value Chain Analysis
6 Global Mesenchymal Stem Cells Market Size Analysis
6.1 By Products and Services
6.1.1
6.1.1.1 Cells and Cell Lines
6.1.1.2 Kits, Media, and Reagents
6.1.2 Services
6.2 By Workflow
6.2.1 Cell Sourcing and Isolation
6.2.2 Culture and Cryopreservation
6.2.3 Differentiation
6.2.4 Characterization
6.3 By Type
6.3.1 Autologous
6.3.2 Allogeneic
6.4 By Source of Isolation
6.4.1 Bone Marrow
6.4.2 Cord Blood
6.4.3 Peripheral Blood
6.4.4 Fallopian Tube
6.4.5 Fetal Liver
6.4.6 Lung
6.4.7 Adipose Tissues
6.5 By Indication
6.5.1 Bone And Cartilage Repair
6.5.2 Cardiovascular Disease
6.5.3 Inflammatory And Immunological Diseases
6.5.4 Liver Diseases
6.5.5 Cancer
6.5.6 GvHD
6.6 By Application
6.6.1 Disease Modelling
6.6.2 Drug Development and Discovery
6.6.3 Stem Cell Banking
6.6.4 Tissue Engineering
6.6.5 Toxicology Studies
7 North America Market Analysis
7.1 By Products and Services
7.1.1
7.1.1.1 Cells and Cell Lines
7.1.1.2 Kits, Media, and Reagents
7.1.2 Services
7.2 By Workflow
7.2.1 Cell Sourcing and Isolation
7.2.2 Culture and Cryopreservation
7.2.3 Differentiation
7.2.4 Characterization
7.3 By Type
7.3.1 Autologous
7.3.2 Allogeneic
7.4 By Source of Isolation
7.4.1 Bone Marrow
7.4.2 Cord Blood
7.4.3 Peripheral Blood
7.4.4 Fallopian Tube
7.4.5 Fetal Liver
7.4.6 Lung
7.4.7 Adipose Tissues
7.5 By Indication
7.5.1 Bone And Cartilage Repair
7.5.2 Cardiovascular Disease
7.5.3 Inflammatory And Immunological Diseases
7.5.4 Liver Diseases
7.5.5 Cancer
7.5.6 GvHD
7.6 By Application
7.6.1 Disease Modelling
7.6.2 Drug Development and Discovery
7.6.3 Stem Cell Banking
7.6.4 Tissue Engineering
7.6.5 Toxicology Studies
7.6 U.S.
7.7 Canada
8 Europe Market Analysis
8.1 By Products and Services
8.1.1
8.1.1.1 Cells and Cell Lines
8.1.1.2 Kits, Media, and Reagents
8.1.2 Services
8.2 By Workflow
8.2.1 Cell Sourcing and Isolation
8.2.2 Culture and Cryopreservation
8.2.3 Differentiation
8.2.4 Characterization
8.3 By Type
8.3.1 Autologous
8.3.2 Allogeneic
8.4 By Source of Isolation
8.4.1 Bone Marrow
8.4.2 Cord Blood
8.4.3 Peripheral Blood
8.4.4 Fallopian Tube
8.4.5 Fetal Liver
8.4.6 Lung
8.4.7 Adipose Tissues
8.5 By Indication
8.5.1 Bone And Cartilage Repair
8.5.2 Cardiovascular Disease
8.5.3 Inflammatory And Immunological Diseases
8.5.4 Liver Diseases
8.5.5 Cancer
8.5.6 GvHD
8.6 By Application
8.6.1 Disease Modelling
8.6.2 Drug Development and Discovery
8.6.3 Stem Cell Banking
8.6.4 Tissue Engineering
8.6.5 Toxicology Studies
8.6 U.K.
8.7 Germany
8.8 France
8.9 Spain
8.10 Italy
8.11 Russia
8.12 Nordic
8.13 Benelux
8.14 Rest of Europe
9 APAC Market Analysis
9.1 By Products and Services
9.1.1
9.1.1.1 Cells and Cell Lines
9.1.1.2 Kits, Media, and Reagents
9.1.2 Services
9.2 By Workflow
9.2.1 Cell Sourcing and Isolation
9.2.2 Culture and Cryopreservation
9.2.3 Differentiation
9.2.4 Characterization
9.3 By Type
9.3.1 Autologous
9.3.2 Allogeneic
9.4 By Source of Isolation
9.4.1 Bone Marrow
9.4.2 Cord Blood
9.4.3 Peripheral Blood
9.4.4 Fallopian Tube
9.4.5 Fetal Liver
9.4.6 Lung
9.4.7 Adipose Tissues
9.5 By Indication
9.5.1 Bone And Cartilage Repair
9.5.2 Cardiovascular Disease
9.5.3 Inflammatory And Immunological Diseases
9.5.4 Liver Diseases
9.5.5 Cancer
9.5.6 GvHD
9.6 By Application
9.6.1 Disease Modelling
9.6.2 Drug Development and Discovery
9.6.3 Stem Cell Banking
9.6.4 Tissue Engineering
9.6.5 Toxicology Studies
9.6 China
9.7 Korea
9.8 Japan
9.9 India
9.10 Australia
9.11 Singapore
9.12 Taiwan
9.13 South East Asia
9.14 Rest of Asia-Pacific
10 Middle East and Africa Market Analysis
10.1 By Products and Services
10.1.1
10.1.1.1 Cells and Cell Lines
10.1.1.2 Kits, Media, and Reagents
10.1.2 Services
10.2 By Workflow
10.2.1 Cell Sourcing and Isolation
10.2.2 Culture and Cryopreservation
10.2.3 Differentiation
10.2.4 Characterization
10.3 By Type
10.3.1 Autologous
10.3.2 Allogeneic
10.4 By Source of Isolation
10.4.1 Bone Marrow
10.4.2 Cord Blood
10.4.3 Peripheral Blood
10.4.4 Fallopian Tube
10.4.5 Fetal Liver
10.4.6 Lung
10.4.7 Adipose Tissues
10.5 By Indication
10.5.1 Bone And Cartilage Repair
10.5.2 Cardiovascular Disease
10.5.3 Inflammatory And Immunological Diseases
10.5.4 Liver Diseases
10.5.5 Cancer
10.5.6 GvHD
10.6 By Application
10.6.1 Disease Modelling
10.6.2 Drug Development and Discovery
10.6.3 Stem Cell Banking
10.6.4 Tissue Engineering
10.6.5 Toxicology Studies
10.6 UAE
10.7 Turkey
10.8 Saudi Arabia
10.9 South Africa
10.10 Egypt
10.11 Nigeria
10.12 Rest of MEA
11 LATAM Market Analysis
11.1 By Products and Services
11.1.1
11.1.1.1 Cells and Cell Lines
11.1.1.2 Kits, Media, and Reagents
11.1.2 Services
11.2 By Workflow
11.2.1 Cell Sourcing and Isolation
11.2.2 Culture and Cryopreservation
11.2.3 Differentiation
11.2.4 Characterization
11.3 By Type
11.3.1 Autologous
11.3.2 Allogeneic
11.4 By Source of Isolation
11.4.1 Bone Marrow
11.4.2 Cord Blood
11.4.3 Peripheral Blood
11.4.4 Fallopian Tube
11.4.5 Fetal Liver
11.4.6 Lung
11.4.7 Adipose Tissues
11.5 By Indication
11.5.1 Bone And Cartilage Repair
11.5.2 Cardiovascular Disease
11.5.3 Inflammatory And Immunological Diseases
11.5.4 Liver Diseases
11.5.5 Cancer
11.5.6 GvHD
11.6 By Application
11.6.1 Disease Modelling
11.6.2 Drug Development and Discovery
11.6.3 Stem Cell Banking
11.6.4 Tissue Engineering
11.6.5 Toxicology Studies
11.6 Brazil
11.7 Mexico
11.8 Argentina
11.9 Chile
11.10 Colombia
11.11 Rest of LATAM
12 Competitive Landscape
12.1 Global Mesenchymal Stem Cells Market Share By Players
12.2 M & A Agreements & Collaboration Analysis
13 Market Players Assessment
13.1 American International Industries (GIGI)
13.1.1 Overview
13.1.2 Business Information
13.1.3 Revenue
13.1.4 ASP
13.1.5 Swot Analysis
13.1.6 Recent Developments
13.2 Cell Applications, Inc.
13.3 Axol Biosciences Ltd.
13.4 Cytori Therapeutics Inc
13.5 STEMCELL Technologies
13.6 Cyagen Biosciences.
13.7 Celprogen Inc
13.8 BrainStorm Cell Limited.
13.9 Stemedica Cell Technologies Inc
13.10 Merck KGaA (MilliporeSigma)
13.11 Lonza
13.12 PromoCell GmbH
14 Research Methodology
14.1 Research Data
14.1.1 Secondary Data
14.1.1.1 Major secondary sources
14.1.1.2 Key data from secondary sources
14.1.2 Primary Data
14.1.2.1 Key data from primary sources
14.1.2.2 Breakdown of primaries
14.1.3 Secondary And Primary Research
14.1.3.1 Key industry insights
14.2 Market Size Estimation
14.2.1 Bottom-Up Approach
14.2.2 Top-Down Approach
14.2.3 Market Projection
14.3 Research Assumptions
14.3.1 Assumptions
14.4 Limitations
14.5 Risk Assessment
15 Appendix
15.1 Discussion Guide
15.2 Customization Options
15.3 Related Reports
16 Disclaimer

$3,500
$4,500

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings